CIK 0001157601 · Large accelerated filer
MADRIGAL PHARMACEUTICALS, INC.
Sign in to watch- Ticker
- MDGL
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 824-2827
- Business address
- 1001 CONSHOHOCKEN STATE ROAD, SUITE 2-350, WEST CONSHOHOCKEN, PA
- Former names
- MADRIGAL PHARMACEUTICALS, INC., SYNTA PHARMACEUTICALS CORP
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Financial Officer sold 10,099 shares at $287.46 ($2,903,059)
- 4 Open-market sale Director sold 274,092 shares at $287.46 ($78,790,486)
- 4 Open-market sale Chief Executive Officer sold 73,526 shares at $287.46 ($21,135,784)
- 4 Open-market sale Chief Medical Officer, EVP R&D sold 73,526 shares at $287.46 ($21,135,784)
- 4 Open-market sale Director sold 280,000 shares at $287.46 ($80,488,800)
- 8-K Event Material agreement
- 424B5 Offering Prospectus
- 424B5 Offering Prospectus
- S-3ASR Offering Registration Statement
- 8-K Event Other events
- 8-K Event Results of operations
- 10-Q Report Quarterly Report
- S-8 Other Securities Offered to Employees in Benefit Plans
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 8-K Event Results of operations
- 10-K Report Annual Report
Page 29 of 62 · 1,224 filings